Rapid Determination of Antibody-Antigen Affinity by Mass Photometry
February 8th, 2021
7.4K views
We describe a single-molecule approach to antigen-antibody affinity measurements using mass photometry (MP). The MP-based protocol is fast, accurate, uses a very small amount of material, and does not require protein modification.
Overview
This article presents a detailed protocol for measuring the specificity and affinity of antigen-antibody interactions using mass photometry (MP), a single-molecule technique. MP enables rapid, label-free, and immobilization-free quantification of molecular masses and populations of antibodies and antigen-antibody complexes, providing insights into binding affinity, stoichiometry, and oligomeric state with minimal sample requirements.
Key Study Components
Area of Science
- Biochemistry
- Immunology
- Protein-protein interactions
Background
- Antibodies are widely used in research, diagnostics, and therapeutics.
- Accurate measurement of antigen-antibody binding affinities is essential for these applications.
- Traditional methods often require labeling or immobilization, which can introduce artifacts.
- Mass photometry offers a rapid, label-free alternative for characterizing protein interactions at the single-molecule level.
Purpose of Study
- To provide a step-by-step protocol for using mass photometry to measure antigen-antibody binding affinities.
- To demonstrate the technique's ability to determine stoichiometry and oligomeric states of protein complexes.
- To outline data analysis procedures for extracting quantitative binding information.
Methods Used
- Preparation and cleaning of coverslips for flow chamber assembly.
- Preparation of antibody and antigen samples, including filtration, centrifugation, and concentration determination by UV absorbance.
- Incubation of antibody-antigen mixtures to reach equilibrium.
- Mass photometry measurements using a flow chamber and microscope setup.
- Data acquisition and analysis, including histogram plotting, Gaussian fitting, and calculation of concentration fractions and dissociation constants using spreadsheet software.
Main Results
- MP enables rapid measurement of antigen-antibody binding affinities using picomole quantities of protein.
- The technique provides information on the relative concentrations of free antibody, single, and double antigen-antibody complexes.
- Global fitting of titration data yields accurate dissociation constants (KD) for the interaction.
- MP can also assess protein oligomerization and sample purity in the same experiment.
Conclusions
- Mass photometry is a simple, efficient, and label-free method for quantifying antigen-antibody interactions.
- The protocol is suitable for proteins larger than 50 kDa and provides best results with sub-micromolar affinities and pure samples.
- Careful experimental design and data analysis are essential for accurate affinity determination.
Frequently Asked Questions
What is mass photometry and how does it work?
Mass photometry is a single-molecule technique that measures the mass of individual molecules in solution by detecting light scattering as they land on a glass surface. It allows for label-free quantification of molecular species and their complexes.
What are the advantages of using mass photometry for antigen-antibody binding studies?
MP requires no labeling or immobilization, uses minimal sample amounts, provides rapid results, and simultaneously yields information on binding affinity, stoichiometry, and oligomeric state.
What sample requirements are necessary for successful MP measurements?
Samples should be relatively pure, with antigens of at least 20 kDa and proteins larger than 50 kDa for optimal results. Sub-micromolar affinities are best suited for this technique.
How is data analyzed after mass photometry measurements?
Data is processed by plotting molecular mass histograms, fitting Gaussian peaks to determine species concentrations, and calculating dissociation constants using spreadsheet-based global fitting.
Can mass photometry be used for proteins other than antibodies?
Yes, the protocol is applicable to strong protein-protein interactions involving proteins with molecular masses greater than 50 kDa.
What are the limitations of mass photometry in this context?
MP is less effective for low-affinity interactions, small antigens (<20 kDa), or impure samples. The single-molecule, label-free approach also imposes some experimental constraints.
How can experimental accuracy be improved in MP-based affinity measurements?
Careful selection of protein concentrations to populate all reaction species, performing titration series, and repeating experiments to calculate standard deviations are recommended for reliable results.
Executive Industry Relevance
Rapid, label-free quantification of antibody-antigen affinity is essential for accelerating therapeutic antibody discovery and optimizing candidate selection. Mass photometry enables single-molecule resolution of binding events, supporting predictive confidence in early-stage target validation and mechanistic de-risking. This approach streamlines portfolio triage by delivering quantitative affinity and stoichiometry data with minimal sample requirements.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables direct measurement of antibody-antigen binding affinities without labeling artifacts.
- Provides quantitative stoichiometry and oligomeric state data for mechanistic de-risking.
- Supports rapid hypothesis testing and functional target validation with picomole-scale samples.
- Facilitates portfolio triage by distinguishing high-affinity candidates early.
Screening & Assay Development
- Delivers validated, quantitative affinity data for downstream screening workflows.
- Standardizes assay outputs by eliminating immobilization and label variability.
- Enables reproducible, scalable affinity measurements across antibody panels.
- Supports reliable compound evaluation by confirming binding specificity and purity.
Translational & Preclinical Research
- Aligns affinity measurements with translational biomarker requirements when antigens are disease-relevant.
- Ensures continuity from discovery to preclinical validation by providing robust KD values.
- Reduces risk of late-stage attrition due to inaccurate binding characterization.
Pipeline & Workflow Integration
Mass photometry positions affinity determination at the interface of early discovery and lead identification, enabling rapid go/no-go decisions before resource-intensive preclinical work.
- Discovery Biology: Supports hypothesis testing and pathway clarification by quantifying binding events at single-molecule resolution.
- Screening: Provides reproducible, quantitative affinity outputs for assay readiness and compound triage.
- Analytics: Delivers molecular mass distributions, stoichiometry, and KD values for comparative analysis.
- Translational Research: Facilitates alignment with disease-relevant targets when sample purity and size criteria are met.
- Enterprise Reuse: Offers a reusable, label-free platform for diverse protein-protein interaction studies above 50 kDa.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in target validation.
- Operational Value: Streamlines workflows with rapid, standardized, and scalable affinity measurements.
- Strategic Value: Enables informed go/no-go decisions and capital-efficient portfolio advancement.
- Portfolio Impact: Supports risk-adjusted prioritization by providing robust, quantitative binding data early in the pipeline.
Implementation Considerations
- Requires expertise in single-molecule data analysis and quantitative fitting.
- Needs access to mass photometry instrumentation and compatible analytical software.
- Demands cross-team standardization of sample preparation and data interpretation.
- Best suited for proteins above 50 kDa and sub-micromolar affinities with high sample purity.
- Limited by reduced sensitivity for small antigens or low-affinity interactions.
Biopharma FAQs
Why does null hypothesis testing matter for antibody-antigen affinity determination?
Null hypothesis testing ensures that observed binding affinities are statistically significant and not due to random variation, supporting robust target validation decisions. In mass photometry, quantitative outputs enable clear differentiation between specific and nonspecific interactions. This rigor underpins confidence in advancing antibody candidates.
How does independent variable isolation fit into mass photometry affinity workflows?
By titrating antigen concentrations while holding antibody levels constant, mass photometry isolates the effect of antigen concentration on binding, enabling precise affinity calculations. This controlled approach supports reproducible, interpretable data for discovery-stage decision-making. It also facilitates mechanistic de-risking by clarifying binding dynamics.
What do quantitative dependent variable measurements enable in mass photometry?
Quantitative measurements of molecular mass distributions and species concentrations allow direct calculation of binding stoichiometry and dissociation constants (KD). These outputs provide actionable data for comparing antibody candidates and optimizing lead selection. They also support cross-functional data integration in R&D pipelines.
Why are replication requirements critical for cross-functional antibody affinity studies?
Replication ensures that affinity measurements are robust and reproducible across experiments and teams, reducing the risk of false positives or negatives. In mass photometry, repeated titrations and standard deviation calculations validate the reliability of KD values. This consistency is essential for collaborative portfolio advancement.
What statistical analysis capabilities are required before implementing mass photometry affinity data?
Teams must be able to perform Gaussian fitting of mass histograms, global fitting of titration series, and error projection or standard deviation analysis. These capabilities ensure accurate extraction of binding parameters and support data-driven go/no-go decisions. Proper statistical rigor underpins enterprise-level confidence in affinity data.
Chapters in this video
0:05
Introduction
0:52
Flow Chamber Preparation and Assembly
2:02
Antibody-Antigen Samples Preparation
3:00
Mass Photometry Measurement
4:36
Mass Photometry Data Analysis
6:34
Equilibrium Constant Value Calculation
8:23
Results: Representative Antibody-Antigen Affinity
9:30
Conclusion
